Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Sauteur, Patrick M Meyer; Chalker, Victoria J; Berger, Christoph; Nir-Paz, Ran; Beeton, Michael L

Sauteur, Patrick M Meyer; Chalker, Victoria J; Berger, Christoph; Nir-Paz, Ran; Beeton, Michael L.

Sauteur PMM; Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich 8032, Switzerland. Electronic address: patrick.meyersauteur@kispi.uzh.ch.
Chalker VJ; United Kingdom Health Security Agency, London, UK.
Berger C; Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich 8032, Switzerland.
Nir-Paz R; Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Beeton ML; Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, UK.

Lancet Microbe ; 3(12): e897, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-1984301

Subject(s)

COVID-19; Pneumonia, Mycoplasma; Humans; Mycoplasma pneumoniae; COVID-19/epidemiology; Pandemics; Pneumonia, Mycoplasma/epidemiology; Antibodies, Bacterial

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Mycoplasma / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Lancet Microbe Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google